Literature DB >> 8492304

Na+, K+, Cl- cotransport and its regulation in Ehrlich ascites tumor cells. Ca2+/calmodulin and protein kinase C dependent pathways.

B S Jensen1, F Jessen, E K Hoffmann.   

Abstract

Net Cl- uptake as well as unidirectional 36Cl influx during regulatory volume increase (RVI) require external K+. Half-maximal rate of bumetanide-sensitive 36Cl uptake is attained at about 3.3 mM external K+. The bumetanide-sensitive K+ influx found during RVI is strongly dependent on both Na+ and Cl-. The bumetanide-sensitive unidirectional Na+ influx during RVI is dependent on K+ as well as on Cl-. The cotransporter activated during RVI in Ehrlich cells, therefore, seems to transport Na+, K+ and Cl-. In the presence of ouabain and Ba+ the stoichiometry of the bumetanide-sensitive net fluxes can be measured at 1.0 Na+, 0.8 K+, 2.0 Cl- or approximately 1:Na, 1:K, 2:Cl. Under these circumstances the K+ and Cl- flux ratios (influx/efflux) for the bumetanide-sensitive component were estimated at 1.34 +/- 0.08 and 1.82 +/- 0.15 which should be compared to the gradient for the Na+, K+, 2Cl- cotransport system at 1.75 +/- 0.24. Addition of sucrose to hypertonicity causes the Ehrlich cells to shrink with no signs of RVI, whereas shrinkage with hypertonic standard medium (all extracellular ion concentrations increased) results in a RVI response towards the original cell volume. Under both conditions a bumetanide-sensitive unidirectional K+ influx is activated. During hypotonic conditions a small bumetanide-sensitive K+ influx is observed, indicating that the cotransport system is already activated. The cotransport is activated 10-15 fold by bradykinin, an agonist which stimulates phospholipase C resulting in release of internal Ca2+ and activation of protein kinase C. The anti-calmodulin drug pimozide inhibits most of the bumetanide-sensitive K+ influx during RVI. The cotransporter can be activated by the phorbol ester TPA. These results indicate that the stimulation of the Na+, K+, Cl- cotransport involves both Ca2+/calmodulin and protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492304     DOI: 10.1007/BF02260106

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  67 in total

1.  Kinetics of volume-sensitive K transport in human erythrocytes: evidence for asymmetry.

Authors:  D M Kaji
Journal:  Am J Physiol       Date:  1989-06

2.  Endothelial cell sodium-potassium-chloride cotransport. Evidence of regulation by Ca2+ and protein kinase C.

Authors:  M E O'Donnell
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

3.  The number of chloride-cation cotransport sites on Ehrlich ascites cells measured with [3H]bumetanide.

Authors:  E K Hoffmann; M Schiødt; P Dunham
Journal:  Am J Physiol       Date:  1986-05

4.  The flux ratio equation under nonstationary conditions.

Authors:  O Sten-Knudsen; H H Ussing
Journal:  J Membr Biol       Date:  1981       Impact factor: 1.843

5.  Na/K/Cl cotransport in cultured human fibroblasts.

Authors:  N E Owen; M L Prastein
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

6.  Mechanism of angiotensin II stimulation of Na-K-Cl cotransport of vascular smooth muscle cells.

Authors:  N E Owen; K M Ridge
Journal:  Am J Physiol       Date:  1989-10

7.  Regulation of Na-K-Cl cotransport in endothelial cells by atrial natriuretic factor.

Authors:  M E O'Donnell
Journal:  Am J Physiol       Date:  1989-07

8.  The regulation of Na/K/2Cl cotransport and bumetanide binding in avian erythrocytes by protein phosphorylation and dephosphorylation. Effects of kinase inhibitors and okadaic acid.

Authors:  E B Pewitt; R S Hegde; M Haas; H C Palfrey
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

9.  Characterization of Na+/K+/Cl- cotransport in cultured HT29 human colonic adenocarcinoma cells.

Authors:  H D Kim; Y S Tsai; C C Franklin; J T Turner
Journal:  Biochim Biophys Acta       Date:  1988-12-22

10.  Potassium chloride cotransport in steady-state ascites tumor cells. Does bumetanide inhibit?

Authors:  F Aull
Journal:  Biochim Biophys Acta       Date:  1981-05-06
View more
  9 in total

1.  Protein kinase C phosphorylation of purified Na,K-ATPase: C-terminal phosphorylation sites at the alpha- and gamma-subunits close to the inner face of the plasma membrane.

Authors:  Yasser A Mahmmoud; Flemming Cornelius
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

Review 2.  Regulation of K-Cl cotransport: from function to genes.

Authors:  N C Adragna; M Di Fulvio; P K Lauf
Journal:  J Membr Biol       Date:  2004-10-01       Impact factor: 1.843

3.  Kinetics of hyperosmotically stimulated Na-K-2Cl cotransporter in Xenopus laevis oocytes.

Authors:  Eric Delpire; Kenneth B Gagnon
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-20       Impact factor: 4.249

4.  Rapid decrease in cellular sodium and chloride content during cold incubation of cultured liver endothelial cells and hepatocytes.

Authors:  E R Gizewski; U Rauen; M Kirsch; I Reuters; H Diederichs; H D Groot
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

5.  Fate of hypertonicity-stressed corneal epithelial cells depends on differential MAPK activation and p38MAPK/Na-K-2Cl cotransporter1 interaction.

Authors:  José E Capó-Aponte; Zheng Wang; Victor N Bildin; Kathryn S Pokorny; Peter S Reinach
Journal:  Exp Eye Res       Date:  2006-11-30       Impact factor: 3.467

6.  The Na-K-2Cl cotransporter is in a permanently activated state in cytoplasts from Ehrlich ascites tumor cells.

Authors:  E K Hoffmann; F Jessen; P B Dunham
Journal:  J Membr Biol       Date:  1994-03       Impact factor: 1.843

7.  Prolonged incubation with elevated glucose inhibits the regulatory response to shrinkage of cultured human retinal pigment epithelial cells.

Authors:  M M Civan; C W Marano; F W Matschinsky; K Peterson-Yantorno
Journal:  J Membr Biol       Date:  1994-04       Impact factor: 1.843

8.  Cellular Links between Neuronal Activity and Energy Homeostasis.

Authors:  Pavan K Shetty; Francesca Galeffi; Dennis A Turner
Journal:  Front Pharmacol       Date:  2012-03-20       Impact factor: 5.810

9.  Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas.

Authors:  Fei Teng; Meng Guo; Fang Liu; Ce Wang; Jiayong Dong; Lei Zhang; You Zou; Rui Chen; Keyan Sun; Hong Fu; Zhiren Fu; Wenyuan Guo; Guoshan Ding
Journal:  Oncotarget       Date:  2016-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.